– USA, CT – Quantum-Si Incorporated (Nasdaq: QSI), a life sciences company commercializing single-molecule protein sequencing, today announced the appointment of Dr. Vik Bajaj (Ph.D.) to its Board of Directors.
“I am thrilled to welcome Vik to the board of Quantum-Si at a pivotal time as we progress toward launching the world’s first next generation protein sequencing system. Vik is a trailblazer in the field of precision medicine and brings decades of expertise as a scientist and entrepreneur. His appointment will strengthen our team of renowned advisors as we execute our commercialization strategy this year,” said Founder and Executive Chairman, Dr. Jonathan Rothberg.
About Dr. Vikram Bajaj
Dr. Vik Bajaj is a managing director at Foresite Capital, evaluating and pursuing investments at the intersection of technology and life sciences, including in personalized and precision healthcare. Before joining Foresite Capital, Vik was CSO of GRAIL and remains on its Scientific Advisory Board. He is also the co-founder and former CSO of Verily and served as chair of its Scientific Advisory Board. Bajaj retains appointments as an associate professor at the Stanford University School of Medicine and as an affiliate scientist of the Lawrence Berkeley National Laboratory and the University of California, Berkeley, for which he serves on the advisory board of the College of Chemistry. He is an advisor to the Department of Defense through the Defense Science Board’s Task Force on Biology.
“It’s been rewarding to witness such remarkable innovation in next-generation protein sequencing,” said Bajaj. “I look forward to applying my expertise and serving alongside this distinguished roster of industry leaders in support of this ambitious mission.”
Bajaj holds a Ph.D. in physical chemistry from the Massachusetts Institute of Technology. His scientific and engineering awards include the Anatole Abragam Prize (2012), the R&D 100 Award for the most promising commercialized technologies (2011 and 2013), and the Department of Energy’s LBL Innovation Grant (2013). In 2011, he was named as a Visiting Professor at the Chinese Academy of Sciences.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and digitize proteomic research to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
For more information: https://www.quantum-si.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.